Related Experiment Video
Updated: Jun 28, 2025

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Cardiology: What You May Have Missed in 2023
Abdulrahman Alfraih1, Achieng Tago1, Michael Lacombe2
1McMaster University, Hamilton, Ontario, Canada (A.A., A.T.).
Insights
Key 2023 cardiology advances include new treatments for obesity and cardiovascular outcomes, updated myocardial infarction (MI) management, and innovative transcatheter therapies for valve regurgitation. These findings offer improved patient care strategies.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Clinical Cardiology
Background:
- Cardiology research continually evolves, introducing novel therapeutic strategies for diverse cardiovascular conditions.
- A comprehensive review of over 1300 articles identified significant cardiology publications from 2023.
Purpose of the Study:
- To summarize pivotal cardiology research published in 2023, focusing on advancements in prevention, treatment, and management of various cardiac conditions.
- To highlight key findings relevant to clinical practice and future research directions in cardiovascular medicine.
Main Methods:
- Systematic screening of over 1300 cardiology articles published in 2023.
- Selection and synthesis of studies addressing prevention, acute coronary syndromes, heart failure, arrhythmias, and structural heart disease.
Main Results:
- Semaglutide's effect on obesity and cardiovascular outcomes, and bempedoic acid's cardiovascular benefits were examined.
- Evidence comparing conservative versus invasive management for frail, older patients with non-ST-segment elevation myocardial infarction (NSTEMI) was reviewed.
- The STREAM-2 trial's findings on half-dose thrombolysis for ST-segment elevation myocardial infarction (STEMI) in older adults were discussed.
- Guideline-directed medical therapy for heart failure, noninvasive testing (coronary computed tomography angiography) for stable coronary artery disease, anticoagulation in device-detected atrial fibrillation, and transcatheter mitral/tricuspid regurgitation treatments were highlighted.
Conclusions:
- The reviewed 2023 cardiology literature showcases significant progress in pharmacotherapy, interventional techniques, and patient management strategies.
- These advancements offer potential for improved cardiovascular outcomes across a spectrum of patient populations, from prevention to complex structural heart interventions.
Abstract:
Cardiology and all its subspecialties continue to push the envelope in developing new treatment strategies for a wide variety of diseases. After screening more than 1300 articles, we highlight a selection of important cardiology articles published in 2023. Starting with prevention, we note articles that look at the effect of semaglutide in patients with obesity as well as a first-in-class drug, bempedoic acid, on cardiovascular outcomes. We have also examined new evidence comparing conservative management with invasive management of frail, older patients with non-ST-segment elevation myocardial infarction (NSTEMI). In patients with cardiac arrest secondary to NSTEMI, another article examines the rationale for expedited transfer to a cardiac arrest center. The STREAM-2 (Strategic Reperfusion in Elderly Patients Early After Myocardial Infarction) trial builds on looking at half-dose thrombolysis in older populations with STEMI. Emphasis is placed on guideline-directed medical therapy before hospital discharge in those with heart failure. In addition, in patients with stable symptomatic coronary artery disease, initial noninvasive testing using coronary computed tomography angiography may be a viable option compared with invasive strategies. More details have emerged on anticoagulation strategies in those with device-detected atrial fibrillation. Finally, transcatheter approaches to treat both mitral and tricuspid regurgitation have also been included.
Related Concept Videos
Development of the Heart
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
Pathophysiology of Cardiac Performance
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...

